Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COST: Sequential PegIFN in Chronic Hepatitis B
NCT03357822Phase 4Unknown
- Sponsor
- Tongji Hospital
- Start
- Jan 2018
- Primary completion
- Jan 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of pegylated interferon alpha in Chronic Hepatitis B (CHB), sponsored by Tongji Hospital. Status: unknown.
02
Drugs
pegylated interferon alpha
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT03357822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03357822.